Apollomics (APLM) traded down -0.73 % during a 24 hours period ending at 11:51 PM Central Europe on Monday 26th. One Apollomics stock can currently be bought for about USD 19.9 on popular exchanges. Current supply of Apollomics stocks is 2.2 mn. Apollomics has a current market capitalization of USD 48 mn and approximately USD 157.2 k worth of Apollomics was traded on exchanges in the last 24 hours. Since last month end, Apollomics has traded -6.98 % down. Simple moving average of last 200 days is at USD 18.97. The highest price of past 52 weeks was recorded at USD 28.29 on 09/03/2026. 52 weeks low was at USD 10.01 on 10/30/2025.
Here is how related stocks have performed in the past 24 hours:
Marchex (MCHX) traded up 0.78 % and now trades at USD 1.26. Marchex has a market capitalisation of USD 57.2 mn.
Caribou Biosciences (CRBU) traded down -4.82 % and now trades at USD 0.49. Caribou Biosciences has a market capitalisation of USD 57.1 mn.
New Fortress Energy (NFE) traded down -1.97 % and now trades at USD 3.32. Current market capitalisation for New Fortress Energy is USD 56.8 mn.
Veritone (VERI) traded flat 0 % and now trades at USD 0.57. Current market capitalisation for Veritone is USD 57.3 mn.
Heron Therapeutics (HRTX) traded flat 0 % and now trades at USD 0.3. Heron Therapeutics has a market capitalisation of USD 57.5 mn.
About Apollomics
Apollomics Inc. is an emerging life sciences oncology company based in Santa Clara, United States. The company specializes in developing medications targeting the growth and proliferation of cancer cells. As a health care sector player, CBT Pharmaceuticals serves customers worldwide and its official website can be accessed under www.apollomicsinc.com . The company’s stock is traded on the Nasdaq stock exchange.